WallStreetZenWallStreetZen

NASDAQ: GMAB
Genmab A Earnings & Revenue

GMAB past earnings growth

How has GMAB's earnings growth performed historically?
Company
3.78%
Industry
23.97%
Market
129.89%
GMAB's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GMAB's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
GMAB's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

GMAB past revenue growth

How has GMAB's revenue growth performed historically?
Company
15.36%
Industry
89.08%
Market
19.74%
GMAB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GMAB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GMAB's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GMAB earnings and revenue history

Current Revenue
$2.6B
Current Earnings
$788.9M
Current Profit Margin
30.7%

GMAB Return on Equity

Current Company
17.6%
Current Industry
16.8%
Current Market
28.2%
GMAB's Return on Equity (17.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GMAB announces earnings.

GMAB Return on Assets

Current Company
15.7%
Current Industry
3.2%
GMAB is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GMAB Return on Capital Employed

Current Company
23.76%
Current Industry
-42.4%
GMAB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GMAB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GMAB$2.56BN/A$784.32M+42.16%+29.55%
BMRN$2.47B$359.85M$205.46M+10.23%+14.24%
RPRX$2.24B$983.33M$798.86M+4.46%+57.82%
BGNE$2.76B-$713.52M-$784.43M+62.54%N/A
BNTX$2.94B$397.96M$121.51M+121.89%-96.92%

GMAB earnings dates

Next earnings date
Aug 1, 2024

Genmab A Earnings & Revenue FAQ

What were GMAB's earnings last quarter?

On Invalid Date, Genmab A (NASDAQ: GMAB) reported Q1 2024 earnings per share (EPS) of $0.29, up 525.53% year over year. Total Genmab A earnings for the quarter were $191.75 million. In the same quarter last year, Genmab A's earnings per share (EPS) was $0.05.

If you're new to stock investing, here's how to buy Genmab A stock.

What was GMAB's earnings growth in the past year?

As of Q3 2024, Genmab A's earnings has grown 3.78% year over year. This is 20.19 percentage points lower than the US Biotechnology industry earnings growth rate of 23.97%. Genmab A's earnings in the past year totalled $784.32 million.

What is GMAB's earnings date?

Genmab A's earnings date is Invalid Date. Add GMAB to your watchlist to be reminded of GMAB's next earnings announcement.

What was GMAB's revenue last quarter?

On Invalid Date, Genmab A (NASDAQ: GMAB) reported Q1 2024 revenue of $599.57 million up 44.5% year over year. In the same quarter last year, Genmab A's revenue was $414.93 million.

What was GMAB's revenue growth in the past year?

As of Q3 2024, Genmab A's revenue has grown 15.36% year over year. This is 73.72 percentage points lower than the US Biotechnology industry revenue growth rate of 89.08%. Genmab A's revenue in the past year totalled $2.56 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.